BRIEF published on 10/15/2024 at 15:05, 1 year 1 month ago KindlyMD Announces $500,000 Stock Repurchase Program Shareholder Value Market Conditions Stock Repurchase Healthcare Company KindlyMD
PRESS RELEASE published on 10/15/2024 at 15:00, 1 year 1 month ago KindlyMD(TM) Announces $500,000 Share Repurchase Program KindlyMD, Inc. authorizes a $500,000 stock repurchase program, aiming to enhance shareholder value. The program may be made through various methods, considering market conditions Shareholder Value Stock Repurchase KindlyMD Patient-first Healthcare Integrated Therapies
BRIEF published on 10/08/2024 at 15:05, 1 year 1 month ago KindlyMD Secures Contract with UnitedHealthcare Healthcare Expansion Utah KindlyMD UnitedHealthcare Health Insurance
PRESS RELEASE published on 10/08/2024 at 15:00, 1 year 1 month ago KindlyMD(TM) Announces Contract with United Healthcare Insurance, the Largest Health Insurer in the United States KindlyMD, Inc. announces its new contract with UnitedHealthcare Insurance, expanding coverage and access for patients in Utah, leading to potential revenue growth Utah Contract KindlyMD UnitedHealthcare Expanded Coverage
BRIEF published on 10/01/2024 at 15:05, 1 year 2 months ago KindlyMD(TM) to Participate in Upcoming October Conferences Medical Cannabis KindlyMD Tim Pickett Benzinga Conference LD Micro
PRESS RELEASE published on 10/01/2024 at 15:00, 1 year 2 months ago KindlyMD(TM) to Participate in Upcoming October Conferences KindlyMD, Inc. CEO to participate in investor conferences discussing medical cannabis experience best practices. Company integrates healthcare strategies with alternative therapies Investor Conferences Medical Cannabis KindlyMD Inc. Healthcare Data Alternative Therapies
BRIEF published on 09/12/2024 at 15:05, 1 year 2 months ago KindlyMD Recognized with Healthcare AI Impact Award 2024 AI Healthcare Medical Cannabis Awards Patient Data
PRESS RELEASE published on 09/12/2024 at 15:00, 1 year 2 months ago KindlyMD(TM) Recognized with Healthcare AI Impact Award 2024 KindlyMD, Inc. wins Healthcare AI Impact Award 2024 for innovative AI-driven patient diagnostics, focusing on medical cannabis use in treatment to improve patient outcomes. Learn more at www.kindlymd.com Patient Outcomes Medical Cannabis KindlyMD Inc. Healthcare AI Impact Award 2024 AI-driven Patient Diagnostics
BRIEF published on 08/29/2024 at 15:05, 1 year 3 months ago KindlyMD Appoints Jeremy Joyal, MD as Medical Director Healthcare Pain Management KindlyMD Medical Director Jeremy Joyal
PRESS RELEASE published on 08/29/2024 at 15:00, 1 year 3 months ago KindlyMD(TM) Appoints Jeremy Joyal, MD as Medical Director KindlyMD, Inc. appoints Dr. Joyal, MD, as Medical Director to oversee clinical practices and develop pain management program protocols. Dr. Joyal brings expertise in Anesthesiology, Pain Medicine, and Addiction Medicine Anesthesiology Pain Management KindlyMD Medical Director Dr. Joyal
Published on 12/05/2025 at 02:35, 1 hour 55 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 3 hours 30 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 5 hours 25 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 5 hours 30 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 4 hours 40 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 5 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 8 hours 15 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 9 hours 20 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 10 hours 30 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 10 hours 45 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 10 hours 46 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 21 hours 29 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 10 hours ago Declaration of voting rights at the end of November 2025
